Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination

Pei Hao; Wu Zhong; Shiyang Song; Shiyong Fan; Xuan Li

doi:10.1080/22221751.2020.1738279

Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination

Emerg Microbes Infect. 2020 Mar 8;9(1):545-547. doi: 10.1080/22221751.2020.1738279. eCollection 2020.

Authors

Pei Hao¹, Wu Zhong², Shiyang Song¹, Shiyong Fan², Xuan Li³

Affiliations

¹ Key Laboratory of Molecular Virology and Immunology, Institute Pasteur of Shanghai, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Shanghai, People's Republic of China.
² National Engineering Research Center For the Emergence Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing, People's Republic of China.
³ Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai, People's Republic of China.

No abstract available

MeSH terms

Base Sequence
Betacoronavirus / genetics*
Betacoronavirus / isolation & purification
COVID-19
Coronavirus Infections / epidemiology
Disease Outbreaks
Genetic Engineering
Humans
Pneumonia, Viral / epidemiology
Recombination, Genetic
SARS-CoV-2

Grants and funding

This work was supported by research grant from the National Science and Technology Major Project for “Major New Drugs Innovation and Development” [2018ZX09711003] of China.